New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Actuate Therapeutics, Inc. (ACTU) vs Bolt Biotherapeutics, Inc. (BOLT)
- Actuate Therapeutics, Inc. ACTU 0.23 +9.52%
- Bolt Biotherapeutics, Inc. BOLT 4.91 −2.96%
Actuate Therapeutics, Inc. and Bolt Biotherapeutics, Inc. are both Biotechnology companies. Actuate Therapeutics, Inc. and Bolt Biotherapeutics, Inc. are of similar size ($13.2M and $12.9M). Across the 9 metrics below, Bolt Biotherapeutics, Inc. leads on 6 and Actuate Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | ACTU | BOLT | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 70.18% |
| Operating margin | — | (654.53%) | 0.00% |
| Net margin | — | (611.47%) | 0.00% |
| Free cash flow margin | — | (655.72%) | 0.00% |
| Return on equity | (364.70%) | (127.96%) | (51.58%) |
| Return on assets | (176.44%) | (51.70%) | (45.91%) |
| Return on invested capital | 0.00% | (154.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack